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CASE STUDY
A rare association of tuberculous 
longitudinally extensive transverse myelitis 
(LETM) with brain tuberculoma
Rajendra Singh Jain1, Sunil Kumar1*  and Shankar Tejwani2
Abstract 
Background: Longitudinally extensive transverse myelitis is characterized by contiguous inflammatory lesion of 
spinal cord involving three or more spinal segments. It is a well-recognized but rare presentation of Mycobacterium 
tuberculosis infection.
Case description: We report a case of young boy diagnosed with multiple brain tuberculomas. He was on antitu-
bercular drugs therapy for 2 months and became asymptomatic. On 2-month followup visit, the patient complained 
of acute onset progressive sensorimotor, spastic paraparesis with bladder dysfunction. Magnetic resonance imaging 
of spine showed longitudinally extensive transverse myelitis extending from thoracic spinal segment T2 to T10 level. 
He was treated with high dose intravenous methylprednisolone therapy and continued on combination of first line 
four antitubercular drugs. At 6-month followup, patient was able to walk with support. In our patient, clinical features, 
previous history of brain tuberculoma and spinal neuroimaging confirmed the diagnosis of tuberculous myelitis. The 
new onset longitudinally extensive transverse myelitis in our patient was may be related to paradoxical response to 
antitubercular therapy.
Conclusions: Our case highlights that tubercular infection might be an important but overlooked cause of longi-
tudinally extensive transverse myelitis. Therefore, clinicians should have a high index of suspicion to diagnose this 
potentially treatable cause especially in high-risk conditions like tuberculosis endemic areas, associated brain tubercu-
losis and HIV infection. Our case is unique because of paradoxical presentation of longitudinally extensive transverse 
myelitis in cranial tuberculomas, already on antitubercular treatment.
Keywords: Tuberculous myelitis, Longitudinally extensive transverse myelitis (LETM), Brain tuberculoma, Tuberculosis
© 2015 Jain et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://
creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided 
you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate 
if changes were made.
Background
The most common central nervous system (CNS) mani-
festations of TB is tuberculous meningitis (95  %), fol-
lowed by cerebral tuberculoma and tuberculous abscess. 
Other infrequent manifestations are calvarial tubercu-
losis, tuberculous pachymeningitis (Tariq and Ahmed 
2012) and spinal arachnoiditis (Naidoo et  al. 1991). 
Intramedullary spinal tuberculosis is an uncommon pres-
entation. There have been few case reports of intramed-
ullary spinal tuberculosis in literature (Lin et  al. 1994). 
Longitudinally extensive transverse myelitis (LETM) is 
characterized by contiguous immune-mediated inflam-
matory lesion of spinal cord extending to three or more 
spinal cord segments (West 2013). Tuberculosis is a rare 
cause of LETM.
Case description
An 18-year old boy had mild grade fever, headache, 
recurrent vomiting and confusion for 2  months. The 
magnetic resonance imaging (MRI) of brain showed 
multiple intraparenchymal lesions involving brain-
stem and anterior temporal lobe. These lesions were 
isointense on T1-weighted (Fig.  1a), hyperintense on 
T2-weighted (Fig.  1b–d) and fluid attenuated inversion 
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recovery (FLAIR) (Fig. 1e) images. There was no central 
hyperintensity on T2-weighted image. Perilesional vaso-
genic edema was present and Gadolinium-enhanced 
T1-weighted images (Fig.  1f–h) showed multiple ring 
enhancing conglomerate lesions. He was diagnosed as 
multiple intracranial tuberculomas with hydrocephalus. 
Ventriculoperitoneal shunt surgery was done and patient 
was started on first line antitubercular drugs (isoniazid, 
rifampin, pyrazinamide and ethambutol) along with cor-
ticosteroids and pyridoxine. At 2 month follow-up visit, 
he complained of acute onset weakness in both lower 
limbs and urinary incontinence for 5  days. There was 
no history of headache, fever, visual blurring, seizures, 
altered sensorium or noncompliance to treatment. On 
examination, higher mental functions, speech and cranial 
nerves including bilateral fundi were normal. The muscle 
power was medical research council (MRC) grade 2/5 in 
both lower limbs and normal in upper limbs. Deep ten-
don reflexes (knee and ankle) were exaggerated (+++) 
and Babinski sign were positive in both lower limbs. All 
the modalities of sensation including pain, touch, tem-
perature, joint position and vibration were impaired 
below thoracic 5 (T5) spine level. There were no menin-
geal or cerebellar signs.
Hemogram, biochemistry including liver functions, 
renal functions, thyroid function tests and serum vitamin 
B12 level were normal. Skin tuberculin sensitivity test 
was positive. Erythrocyte sedimentation rate (ESR) was 
raised (54 in first hour). Computed tomography (CT) of 
thorax and abdomen were normal. Serum ELISA test for 
human immunodeficiency virus (HIV) was negative. The 
markers for autoimmune and connective tissue disorders 
(ANA, Anti-ds DNA, Anti-nucleosome, Anti-histones, 
Anti-Sm, Anti SS-A, Anti RO, Anti Scl-70, Anti Rib-P-
Protein, Anti-JO, Anti-SS-B) were negative.
The magnetic resonance imaging (MRI) of thoracic 
spine showed contiguous long segment intramedullary 
lesion, which was isointense on T1-weighted and hyper-
intense on T2-weighted images extending from thoracic 
vertebral level T2 to T10. There was no cord expansion 
or contrast enhancement (Figs.  2a–c, 3a–d). The MRI 
features were suggestive of longitudinally extensive trans-
verse myelitis (LETM). The MRI of brain showed no new 
changes.
Lumbar puncture showed normal intracranial pressure 
(140 mm H2O). Cerebrospinal fluid (CSF) analysis revealed 
75 cells/mm3 with lymphocytic pleocytosis (Lymphocyte: 
90  %, Neutrophils: 10  %), elevated protein (150  mg/dL) 
Fig. 1 MRI of brain shows multiple intraparenchymal lesions involving brainstem and anterior temporal lobe. These lesions are isointense to grey 
matter on T1-weighted (a), hyperintense on T2-weighted (b, c, d) and fluid attenuated inversion recovery (FLAIR) (e) images. There is no central 
hyperintensity on T2-weighted image. Surrounding perilesional vasogenic edema is present. Gadolinium-enhanced T1-weighted images (f, g, h) 
shows multiple conglomerated ring enhancement. Ventriculoperitoneal shunt in situ is seen in right lateral ventricle
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and normal glucose (46 mg/dL) levels. CSF acid-fast bacil-
lus (AFB) stain was negative. Culture for Mycobacterium 
tuberculosis and other bacterias were negative. Polymerase 
chain reaction (PCR) for tuberculosis and and Herpes sim-
plex virus were negative. CSF anti-AQP4 antibody (NMO 
antibodies) and oligoclonal bands were negative.
The clinical and imaging findings were consistent 
with the diagnosis of tuberculous LETM [T2-T10] in 
already existing brain tuberculomas. The patient was 
treated with high dose intravenous methylprednisolone 
(1000  mg per day for 5  days) and antitubercular drugs 
which patient was taking continued as such. At the time 
of discharge, he showed mild improvement in mus-
cle power MRC grade 3/5 in both lower limbs. He was 
discharged on four antitubercular drugs on (isoniazid 
300 mg, rifampicin 450 mg, pyrazinamide 1500 mg and 
ethambutol 800 mg), along with pyridoxine (40 mg) and 
dexamethasone (12  mg) per day. Dexamethasone dose 
was tapered off over 8 weeks. Our plan was to continue 
on these antitubercular drugs for 12  months and then 
shift to two antitubercular drug (rifampin and isoniazid) 
for next 6 months. At 6 months followup, he was able to 
walk with minimal support.
Discussion and evaluation
Wadia and Dastur gave the term tuberculous radiculomy-
elitis (TBRM), which included spinal cord complications 
of TBM, arachnoiditis, spinal tuberculoma or granuloma 
(Wadia and Dastur 1969; Wadia 1973). There are few case 
reports describing the radiological features of tubercu-
lous myelopathy (Gupta et  al. 1994). These lesions are 
mostly hypointense to isointense on T1-weighted and 
hyperintense on T2-weighted images without contrast 
enhancement. The largest series of intramedullary spinal 
tuberculosis (15 patients) showed varied MRI changes 
(Ramdurg et al. 2009). Cerebrospinal fluid (CSF) analysis 
in tuberculous myelitis usually shows an active inflamma-
tory response with predominantly lymphocytic pleocyto-
sis and high protein level (Wadia and Dastur 1969).
In our patient clinical features, previous history of brain 
tuberculoma and spinal neuroimaging confirmed the 
diagnosis of tuberculous myelitis. However, other differ-
ential diagnosis like infective (bacterial, viral, parasitic), 
spinal cord tuberculoma, demyelinating disorders (MS, 
NMO), autoimmune and connective tissue disorders, 
vascular, neoplastic or paraneoplastic etiologies were also 
kept in consideration (Kitley et  al. 2012). Spinal neuro-
imaging findings ruled out possibilities of tuberculoma, 
tumors or vascular lesions. Various markers for autoim-
mune and connective tissue disorders like ANA, Anti-ds 
DNA, Anti-nucleosome, Anti-histones, Anti-Sm, Anti 
SS-A, Anti RO, Anti Scl-70, Anti Rib-P-Protein, Anti-JO, 
Anti-SS-B were found to be negative in our patient. Cul-
ture for Mycobacterium tuberculosis and other bacterias 
Fig. 2 Magnetic resonance imaging (MRI) of thoracic spine (sagittal section) showing contiguous long segment intramedullary lesion which is 
isointense on T1-weighted (a) and hyperintense on T2-weighted (b) images extending from thoracic vertebral level T2 to T10. There is no cord 
expansion or contrast enhancement (c)
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were negative. Polymerase chain reaction (PCR) for Her-
pes simplex virus were negative. Anti-AQP4 antibody 
and oligoclonal bands, which are specific for neuromy-
elitis optica (NMO) and multiple sclerosis, respectively 
were negative in our patient (Trebst et al. 2011).
The patient showed marked clinical improvement 
of brain tuberculoma on a combination therapy of four 
antitubercular drugs and dexamethasone for 2  months. 
Though, radiological resolution of tuberculomas occur 
usually after 1  year of antituberculous therapy (Awada 
et  al. 1998). Our patient developed tuberculous LETM 
despite good compliance to therapy. The spinal lesion 
was new in our patient as MRI of spine was completely 
normal 2 months back. It may be related to paradoxical 
response of antitubercular treatment. The paradoxical 
response during antitubercular drug therapy is character-
ized by clinical worsening or appearance of new lesions 
on imaging in a patient who had initially shown response 
and clinical improvement improved with the therapy 
(Cheng et  al. 2002). The etiopathogenesis of this para-
doxical response is still not clear, but various hypotheses 
have been proposed (Cheng et al. 2003; Rao et al. 1995). 
According to one hypothesis, antitubercular drug ther-
apy causes lysis and release of tubercular protein, which 
mediate an intense inflammatory reaction and result 
in new or expansion of the preexisting lesions (Gamage 
et  al. 2000). Other theory suggest an immune reaction 
to tubercular bacilli or a primary tuberculous infection. 
Another possibility is that the antitubercular drug have 
poor penetration into the CSF once the initial inflam-
mation subsides. Another possible explanation may be 
non-effectiveness of antituberculous drugs due to poor 
CSF penetration once the initial inflammation subsides. 
The most likely mechanism of LETM in our patient was 
related to inflammatory reaction to degraded tubercu-
lous proteins due to chemotherapy against Mycobacte-
rium tuberculosis bacilli, which causes appearance of 
new lesions.
A prompt recognition and treatment is necessary to 
prevent irreversible damage and morbidity. There is a 
definite indication of corticosteroids in treatment of 
brain tuberculoma (Wadia and Dastur 1969). Four first 
Fig. 3 T2-weighted MRI of thoracic spine (axial section) showing poorly delineated intramedullary hyperintense lesion (a, b, c, d). There is no cord 
expansion
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line anti-tuberculosis drugs (isoniazid, rifampin, pyrazi-
namide and ethambutol) along with pyridoxine for pro-
longed period (18  months) are recommended for brain 
tuberculoma (van der Harst and Luijckx 2011; Gropper 
et  al. 1995). However, no clear cut guidelines are avail-
able for management of tuberculous myelitis. Since it 
is believed to be an inflammatory reaction, high dose 
intravenous methylprednisolone might have a beneficial 
role in tuberculous LETM. Corticosteroids are therefore 
useful to treat both tuberculous LETM and brain tuber-
culoma in conjunction with continued use of antituber-
culous drugs.
Conclusion
Longitudinally extensive transverse myelitis (LETM) 
is characterized by contiguous inflammatory lesion of 
spinal cord involving three or more spinal cord seg-
ments. LETM is a well-recognized but rare presenta-
tion of Mycobacterium tuberculosis infection. However, 
paradoxical tuberculous LETM in association with brain 
tuberculomas is unique presentation. Our case highlights 
that tuberculosis might be an important but neglected 
cause of myelitis. Therefore, clinicians should have a 
high index of suspicion to diagnose the potentially treat-
able tuberculous myelitis especially in high-risk condi-
tions like tuberculosis endemic area, associated brain 
tuberculosis (meningitis, abscess and tuberculoma), HIV 
infection and also watch out for paradoxical response to 
antitubercular drug therapy.
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